Rafferty Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Sell |
168,390
-1,081
| -0.6% | -$75.5K | 0.04% | 247 |
|
|
2025
Q1 | $12.5M | Sell |
169,471
-27,186
| -14% | -$2M | 0.05% | 218 |
|
|
2024
Q4 | $12.9M | Buy |
196,657
+46,918
| +31% | +$3.07M | 0.05% | 238 |
|
|
2024
Q3 | $11.7M | Sell |
149,739
-7,767
| -5% | -$605K | 0.04% | 261 |
|
|
2024
Q2 | $12.3M | Sell |
157,506
-30,309
| -16% | -$2.36M | 0.05% | 252 |
|
|
2024
Q1 | $12.7M | Buy |
187,815
+20,856
| +12% | +$1.41M | 0.05% | 221 |
|
|
2023
Q4 | $11.2M | Buy |
166,959
+43,464
| +35% | +$2.93M | 0.05% | 240 |
|
|
2023
Q3 | $8.36M | Buy |
123,495
+28,583
| +30% | +$1.94M | 0.05% | 271 |
|
|
2023
Q2 | $6.79M | Buy |
94,912
+15,501
| +20% | +$1.11M | 0.04% | 350 |
|
|
2023
Q1 | $5.51M | Buy |
79,411
+13,922
| +21% | +$966K | 0.04% | 365 |
|
|
2022
Q4 | $4.44M | Sell |
65,489
-50,441
| -44% | -$3.42M | 0.04% | 399 |
|
|
2022
Q3 | $6.36M | Buy |
115,930
+10,272
| +10% | +$563K | 0.07% | 268 |
|
|
2022
Q2 | $6.98M | Buy |
105,658
+1,107
| +1% | +$73.1K | 0.06% | 217 |
|
|
2022
Q1 | $6.94M | Buy |
+104,551
| New | +$6.94M | 0.04% | 271 |
|